XML 24 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 28, 2019
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Investments
The following table summarizes the amortized cost basis of the debt securities (in thousands):
 
December 28, 2019
 
December 29, 2018
Amortized cost basis of debt securities
$
12,542

 
$
12,202



Cash, cash equivalents, and investments are reflected in the Consolidated Balance Sheets and were as follows (in thousands):
 
December 28, 2019
 
December 29, 2018
 
Cash and cash equivalents
 
Short-term investments
 
Other Assets
 
Cash and cash equivalents
 
Short-term investments
 
Other Assets
Debt securities
$

 
$
1,096

 
$
11,566

 
$

 
$
1,327

 
$
10,677

Equity investment

 

 
1,500

 

 

 

Cash and money market accounts
52,073

 

 

 
76,819

 

 

Total
$
52,073

 
$
1,096

 
$
13,066

 
$
76,819

 
$
1,327

 
$
10,677


Allowance for Doubtful Accounts The following table summarizes the change in the allowance for doubtful accounts (in thousands):
 
 
Balance at beginning of period
 
Adjustments to allowance
 
Amounts written off, net of recoveries and other adjustments
 
Balance at end of period
Year ended December 28, 2019
 
$
3,867

 
$
508

 
$
816

 
$
3,559

Year ended December 29, 2018
 
$
1,904

 
$
2,440

 
$
477

 
$
3,867

Year ended December 30, 2017
 
$
2,140

 
$
846

 
$
1,082

 
$
1,904


Schedule Of Inventory Current Table Inventories included in the Consolidated Balance Sheets consisted of the following (in thousands):
 
December 28, 2019
 
December 29, 2018
Finished products
$
118,633

 
$
97,398

Materials and work in process
75,526

 
94,161

Last-in, first-out ("LIFO") allowance
(30,694
)
 
(34,381
)
Total inventories
$
163,465

 
$
157,178

 
 
 
 
 
 
 
 
Inventory valued by the LIFO costing method
65
%
 
81
%

Schedule of Property, Plant and Equipment Total depreciation expense was as follows (in thousands):
 
2019

 
2018

 
2017

Depreciation expense
$
53,022

 
$
51,063

 
$
56,494


Schedule of Accounts Payable and Accrued Liabilities
Accounts payable and accrued expenses are reflected in the Consolidated Balance Sheets and were as follows (in thousands):
 
December 28, 2019
 
December 29, 2018
Trade accounts payable
$
227,557

 
$
221,395

Compensation
53,147

 
52,227

Profit sharing and retirement expense
28,264

 
28,300

Marketing expenses
46,344

 
36,529

Freight
15,998

 
13,892

Other accrued expenses
81,892

 
76,522

 
$
453,202

 
$
428,865


Schedule of Product Warranties The following table summarizes when these estimated settlements are expected to be paid (in thousands):
 
December 28, 2019
 
December 29, 2018
Current - in the next twelve months
$
7,940

 
$
9,455

Long-term - beyond one year
7,925

 
5,995

 
$
15,865

 
$
15,450


Activity associated with warranty obligations was as follows (in thousands):
 
2019

 
2018

 
2017

Balance at beginning of period
$
15,450

 
$
15,388

 
$
15,250

Accruals for warranties issued during period
19,600

 
22,697

 
20,075

Adjustments related to pre-existing warranties
906

 
233

 
194

Settlements made during the period
(20,091
)
 
(22,868
)
 
(20,131
)
Balance at end of period
$
15,865

 
$
15,450

 
$
15,388


Schedule of Product Development Expense The amounts charged against income and recorded in "Selling and administrative expenses" on the Consolidated Statements of Comprehensive Income were as follows (in thousands):
 
2019

 
2018

 
2017

Research and development costs
$
34,699

 
$
33,420

 
$
31,846


Schedule of Freight Expense
Freight expense on shipments to customers was recorded in "Selling and administrative expenses" on the Consolidated Statements of Comprehensive Income as follows (in thousands):
 
2019

 
2018

 
2017

Freight expense
$
123,667

 
$
134,190

 
$
119,096


Schedule of Earnings Per Share, Basic and Diluted
The following table reconciles the numerators and denominators used in the calculation of basic and diluted earnings per share ("EPS") (in thousands, except per share data):
 
2019

 
2018

 
2017

Numerator:
 
 
 
 
 

Numerator for both basic and diluted EPS attributable to HNI Corporation net income
$
110,505

 
$
93,377

 
$
89,795

Denominators:
 
 
 
 
 
Denominator for basic EPS weighted-average common shares outstanding
43,101

 
43,639

 
43,839

Potentially dilutive shares from stock-based compensation plans
394

 
689

 
1,001

Denominator for diluted EPS
43,495

 
44,328

 
44,840

Earnings per share – basic
$
2.56

 
$
2.14

 
$
2.05

Earnings per share – diluted
$
2.54

 
$
2.11

 
$
2.00


Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The weighted-average common stock equivalents presented above do not include the effect of the common stock equivalents in the table below because their inclusion would be anti-dilutive (in thousands):
 
2019

 
2018

 
2017

Common stock equivalents excluded because their inclusion would be anti-dilutive
2,131

 
1,508

 
809


Schedule of Insurance Reserves The general, auto, product, and workers’ compensation liabilities are managed using a wholly-owned insurance captive and the related liabilities are included in the Consolidated Balance Sheets as follows (in thousands):
 
December 28, 2019
 
December 29, 2018
General, auto, product, and workers' compensation liabilities
$
26,233

 
$
30,227